KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

KOREA PHARMA Revenue

KOREA PHARMA had revenue of 24.00B KRW in the quarter ending September 30, 2025, with 24.84% growth. This brings the company's revenue in the last twelve months to 90.11B, up 12.92% year-over-year. In the year 2024, KOREA PHARMA had annual revenue of 81.28B, down -2.36%.

• Revenue (ttm): 90.11B
• Revenue Growth: +12.92%
• P/S Ratio: 1.53
• Revenue / Employee: 672.48M
• Employees: 134
• Market Cap: 137.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	81.28B	-1.96B	-2.36%
Dec 31, 2023	83.24B	2.21B	2.73%
Dec 31, 2022	81.03B	1.45B	1.83%
Dec 31, 2021	79.58B	8.07B	11.28%
Dec 31, 2020	71.51B	5.37B	8.12%